{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:24:35Z","timestamp":1765268675897,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K06511","26430043","42890001"],"award-info":[{"award-number":["18K06511","26430043","42890001"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS093594"],"award-info":[{"award-number":["NS093594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jns.2020.116802","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:22:52Z","timestamp":1585221772000},"page":"116802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation"],"prefix":"10.1016","volume":"413","author":[{"given":"Kentaro","family":"Togashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kotaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arina","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-7087","authenticated-orcid":false,"given":"Toshio","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116802_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00726-001-0111-9","article-title":"L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent","volume":"23","author":"Hornykiewicz","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.jns.2020.116802_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000215875","article-title":"Levodopa: Past, present, and future","volume":"62","author":"Hauser","year":"2009","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2020.116802_bb0015","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jns.2020.116802_bb0020","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1523\/JNEUROSCI.4564-03.2004","article-title":"Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"24","author":"Hayley","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2020.116802_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jns.2020.116802_bb0030","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5247-09.2010","article-title":"Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures","volume":"30","author":"Hensley","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2020.116802_bb0035","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.3390\/molecules15085581","article-title":"Emerging biological importance of central nervous system Lanthionines","volume":"15","author":"Hensley","year":"2010","journal-title":"Molecules."},{"key":"10.1016\/j.jns.2020.116802_bb0040","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/NEN.0b013e3182a74372","article-title":"A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 x Tg-AD mouse model of Alzheimer disease","volume":"72","author":"Hensley","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2020.116802_bb0045","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.neuint.2012.09.013","article-title":"A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia","volume":"61","author":"Nada","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jns.2020.116802_bb0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jnc.13114","article-title":"Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis","volume":"134","author":"Dupree","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2020.116802_bb0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bbrc.2016.12.069","article-title":"Biochemical and biophysical research communications Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroin fl ammation and promoting axon growth","volume":"483","author":"Kotaka","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jns.2020.116802_bb0060","first-page":"1","article-title":"Role of the Akt\/GSK-3\u03b2\/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity","volume":"1602","author":"Fang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2020.116802_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jnc.13617","article-title":"Loss of CRMP4 suppresses dopaminergic neuron death in an MPTP-induced mouse model of Parkinson\u2019s disease","volume":"137","author":"Tonouchi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2020.116802_bb0070","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1073\/pnas.191107398","article-title":"An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson\u2019s disease","volume":"98","author":"Mochizuki","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2020.116802_bb0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuint.2013.03.015","article-title":"Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model","volume":"62","author":"Yadav","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jns.2020.116802_bb0080","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11064-013-1005-4","article-title":"Neuroprotective role of withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism","volume":"38","author":"Prakash","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2020.116802_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jnc.12756","article-title":"Cdk5\/p35 is required for motor coordination and cerebellar plasticity","volume":"131","author":"He","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2020.116802_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jns.2020.116802_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2013.02.066","article-title":"The effect of dopamine on MPTP-induced rotarod disability","volume":"543","author":"Ayton","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2020.116802_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/gtc.12651","article-title":"Genetic suppression of CRMP2 phosphorylation improves outcome in MPTP-induced Parkinson\u2019s model mice","volume":"24","author":"Togashi","year":"2019","journal-title":"Genes Cells"},{"key":"10.1016\/j.jns.2020.116802_bb0105","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1523\/JNEUROSCI.4247-12.2013","article-title":"Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury","volume":"33","author":"Amini","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2020.116802_bb0110","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.2232515100","article-title":"Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson \u2019 s disease","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2020.116802_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jns.2020.116802_bb0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.116802_bb0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson \u2019 s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jns.2020.116802_bb0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson\u2019s disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2020.116802_bb0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.116802_bb0140","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ncb2373","article-title":"ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation","volume":"13","author":"Wakatsuki","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jns.2020.116802_bb0145","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1471-4159.2007.04829.x","article-title":"Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer\u2019s disease progression","volume":"103","author":"Cole","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2020.116802_bb0150","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jnr.20999","article-title":"Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine","volume":"84","author":"Tian","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2020.116802_bb0155","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/nm1505","article-title":"A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord","volume":"12","author":"Kaneko","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2020.116802_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-6606-7-14","article-title":"Rewiring of regenerated axons by combining treadmill training with semaphorin3A inhibition","volume":"7","author":"Zhang","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.jns.2020.116802_bb0165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/emmm.201100179","article-title":"Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition","volume":"3","author":"Renault-Mihara","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jns.2020.116802_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jns.2020.116802_bb0175","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.jns.2020.116802_bb0180","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1523\/JNEUROSCI.5563-11.2012","article-title":"Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization","volume":"32","author":"Yamashita","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2020.116802_bb0185","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2020.116802_bb0190","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.273.37.24057","article-title":"p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"Patrick","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2020.116802_bb0195","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1006\/bbrc.1998.9739","article-title":"Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons","volume":"252","author":"Saito","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jns.2020.116802_bb0200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.2875-05.2006","article-title":"Calpain-regulated p35\/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2","volume":"26","author":"Smith","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2020.116802_bb0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tcb.2011.11.003","article-title":"Cdk5\u202f: a multifaceted kinase in neurodegenerative diseases","volume":"22","author":"Cheung","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jns.2020.116802_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2007.05.033","article-title":"Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson\u2019s disease","volume":"39","author":"Qu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2020.116802_bb0215","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncb2217","article-title":"Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson \u2019 s disease","volume":"13","author":"Wong","year":"2011","journal-title":"Nat. Cell Biol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:51:12Z","timestamp":1758383472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20301386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":43,"alternative-id":["S0022510X20301386"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116802","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116802"}}